NOVA is a leading Healthtech company which simulates in silico clinical trials in virtual patient populations for bio-pharma companies with a need to accelerate and de-risk their R&D.

With over a decade of experience and multiple commercial projects with biotech and pharma companies, NOVA has developed a unique in silico clinical trial simulation platform called Jinkō®.

With BioModeling, Artificial Intelligence and Virtual Populations at the heart of NOVA’s innovative approach, the platform takes its name from the fortunate homonymic collision of the Japanese words for ‘artificial’ (人工, jinkō) and ‘population’ (人口, jinkō).

We accelerate and de-risk clinical development.
In doing so, we bring speed and efficiency gains to pharmaceutical and biotech companies.

Market Access Services